Touloukian CE - Search Results

1

Assumptions of the tumor 'escape' hypothesis.

Restifo NP, Antony PA, Finkelstein SE, Leitner WW, Surman DP, Theoret MR, Touloukian CE. Restifo NP, et al. Among authors: touloukian ce. Semin Cancer Biol. 2002 Feb;12(1):81-6. doi: 10.1006/scbi.2001.0399. Semin Cancer Biol. 2002. PMID: 11926416 Free PMC article. Review.

2

Expression of a "self-"antigen by human tumor cells enhances tumor antigen-specific CD4(+) T-cell function.

Touloukian CE, Leitner WW, Robbins PF, Li YF, Kang X, Lapointe R, Hwu P, Rosenberg SA, Restifo NP. Touloukian CE, et al. Cancer Res. 2002 Sep 15;62(18):5144-7. Cancer Res. 2002. PMID: 12234976 Free PMC article.

3

Normal tissue depresses while tumor tissue enhances human T cell responses in vivo to a novel self/tumor melanoma antigen, OA1.

Touloukian CE, Leitner WW, Schnur RE, Robbins PF, Li Y, Southwood S, Sette A, Rosenberg SA, Restifo NP. Touloukian CE, et al. J Immunol. 2003 Feb 1;170(3):1579-85. doi: 10.4049/jimmunol.170.3.1579. J Immunol. 2003. PMID: 12538723 Free PMC article.

4

Mining the melanosome for tumor vaccine targets: P.polypeptide is a novel tumor-associated antigen.

Touloukian CE, Leitner WW, Robbins PF, Rosenberg SA, Restifo NP. Touloukian CE, et al. Cancer Res. 2001 Nov 15;61(22):8100-4. Cancer Res. 2001. PMID: 11719435 Free PMC article.

5

MHC class I and class II presentation of tumor antigen in retrovirally and adenovirally transduced dendritic cells.

Sloan JM, Kershaw MH, Touloukian CE, Lapointe R, Robbins PF, Restifo NP, Hwu P. Sloan JM, et al. Among authors: touloukian ce. Cancer Gene Ther. 2002 Nov;9(11):946-50. doi: 10.1038/sj.cgt.7700509. Cancer Gene Ther. 2002. PMID: 12386833 Free PMC article.

6

Poor immunogenicity of a self/tumor antigen derives from peptide-MHC-I instability and is independent of tolerance.

Yu Z, Theoret MR, Touloukian CE, Surman DR, Garman SC, Feigenbaum L, Baxter TK, Baker BM, Restifo NP. Yu Z, et al. Among authors: touloukian ce. J Clin Invest. 2004 Aug;114(4):551-9. doi: 10.1172/JCI21695. J Clin Invest. 2004. PMID: 15314692 Free PMC article.

7

Tumor-specific Th17-polarized cells eradicate large established melanoma.

Muranski P, Boni A, Antony PA, Cassard L, Irvine KR, Kaiser A, Paulos CM, Palmer DC, Touloukian CE, Ptak K, Gattinoni L, Wrzesinski C, Hinrichs CS, Kerstann KW, Feigenbaum L, Chan CC, Restifo NP. Muranski P, et al. Among authors: touloukian ce. Blood. 2008 Jul 15;112(2):362-73. doi: 10.1182/blood-2007-11-120998. Epub 2008 Mar 19. Blood. 2008. PMID: 18354038 Free PMC article.

8

Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes.

Overwijk WW, Lee DS, Surman DR, Irvine KR, Touloukian CE, Chan CC, Carroll MW, Moss B, Rosenberg SA, Restifo NP. Overwijk WW, et al. Among authors: touloukian ce. Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):2982-7. doi: 10.1073/pnas.96.6.2982. Proc Natl Acad Sci U S A. 1999. PMID: 10077623 Free PMC article.

9

Recombinant virus vaccination against "self" antigens using anchor-fixed immunogens.

Irvine KR, Parkhurst MR, Shulman EP, Tupesis JP, Custer M, Touloukian CE, Robbins PF, Yafal AG, Greenhalgh P, Sutmuller RP, Offringa R, Rosenberg SA, Restifo NP. Irvine KR, et al. Among authors: touloukian ce. Cancer Res. 1999 Jun 1;59(11):2536-40. Cancer Res. 1999. PMID: 10363968 Free PMC article.

10

Identification of a MHC class II-restricted human gp100 epitope using DR4-IE transgenic mice.

Touloukian CE, Leitner WW, Topalian SL, Li YF, Robbins PF, Rosenberg SA, Restifo NP. Touloukian CE, et al. J Immunol. 2000 Apr 1;164(7):3535-42. doi: 10.4049/jimmunol.164.7.3535. J Immunol. 2000. PMID: 10725708 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20 results

Search Page